Biogen Idec to Present at the 27th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ:BIIB) announced today that its presentation and breakout session at the 27th Annual J.P. Morgan Healthcare Conference will be webcast live via the internet, on Tuesday, January 13, 2009 at 8:00 a.m. PT (11:00 a.m. ET). To access the live webcast, please visit Biogen Idec’s Investor Relations section (investor.biogenidec.com). An archived version of the webcast will be available for 14 days following the presentation.

About Biogen Idec

Biogen Idec creates new standards of care in oncology, neurology and immunology. As a global leader in the development, manufacturing, and commercialization of novel therapies, Biogen Idec transforms scientific discoveries into advances in human healthcare. For product labeling, press releases and additional information about the company, please visit http://www.biogenidec.com.

Contacts

Biogen Idec
Rob Jacobson, 617-679-2812
Investor Relations

Permalink: http://www.businesswire.com/news/google/20090106006167/en

Sharing

Better Be Business Wired.

Business Wire is the leading source for press releases, photos, multimedia and regulatory filings from companies and groups throughout the world.